Literature DB >> 12841848

Insulin-induced Drosophila S6 kinase activation requires phosphoinositide 3-kinase and protein kinase B.

Jose M Lizcano1, Saif Alrubaie, Agnieszka Kieloch, Maria Deak, Sally J Leevers, Dario R Alessi.   

Abstract

An important mechanism by which insulin regulates cell growth and protein synthesis is through activation of the p70 ribosomal S6 protein kinase (S6K). In mammalian cells, insulin-induced PI3K (phosphoinositide 3-kinase) activation, generates the lipid second messenger PtdIns(3,4,5) P (3), which is thought to play a key role in triggering the activation of S6K. Although the major components of the insulin-signalling pathway are conserved in Drosophila, recent studies suggested that S6K activation does not require PI3K in this system. To investigate further the role of dPI3K (Drosophila PI3K) in dS6K (Drosophila S6K) activation, we examined the effect of two structurally distinct PI3K inhibitors on insulin-induced dS6K activation in Kc167 and S2 Drosophila cell lines. We found that both inhibitors prevented insulin-stimulated phosphorylation and activation of dS6K. To investigate further the role of the dPI3K pathway in regulating dS6K activation, we also used dsRNAi (double-stranded RNA-mediated interference) to decrease expression of dPI3K and the PtdIns(3,4,5) P (3) phosphatase dPTEN ( Drosophila phosphatase and tensin homologue deleted on chromosome 10) in Kc167 and S2 cells. Knock-down of dPI3K prevented dS6K activation, whereas knock-down of dPTEN, which would be expected to increase PtdIns(3,4,5) P (3) levels, stimulated dS6K activity. Moreover, when the expression of the dPI3K target, dPKB (Drosophila protein kinase B), was decreased to undetectable levels, we found that insulin could no longer trigger dS6K activation. This observation provides the first direct demonstration that dPKB is required for insulin-stimulated dS6K activation. We also present evidence that the amino-acid-induced activation of dS6K in the absence of insulin, thought to be mediated by dTOR (Drosophila target of rapamycin), which is unaffected by the inhibition of dPI3K by wortmannin. The results of the present study support the view that, in Drosophila cells, dPI3K and dPKB, as well dTOR, are required for the activation of dS6K by insulin.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12841848      PMCID: PMC1223624          DOI: 10.1042/BJ20030577

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  43 in total

Review 1.  Growth control: invertebrate insulin surprises!

Authors:  S J Leevers
Journal:  Curr Biol       Date:  2001-03-20       Impact factor: 10.834

Review 2.  TOR signalling and control of cell growth.

Authors:  G Thomas; M N Hall
Journal:  Curr Opin Cell Biol       Date:  1997-12       Impact factor: 8.382

3.  Cell-autonomous regulation of cell and organ growth in Drosophila by Akt/PKB.

Authors:  J Verdu; M A Buratovich; E L Wilder; M J Birnbaum
Journal:  Nat Cell Biol       Date:  1999-12       Impact factor: 28.824

4.  Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002.

Authors:  G J Brunn; J Williams; C Sabers; G Wiederrecht; J C Lawrence; R T Abraham
Journal:  EMBO J       Date:  1996-10-01       Impact factor: 11.598

Review 5.  Regulation of translation initiation by FRAP/mTOR.

Authors:  A C Gingras; B Raught; N Sonenberg
Journal:  Genes Dev       Date:  2001-04-01       Impact factor: 11.361

6.  Phosphatidylinositol 3-kinase links the interleukin-2 receptor to protein kinase B and p70 S6 kinase.

Authors:  K Reif; B M Burgering; D A Cantrell
Journal:  J Biol Chem       Date:  1997-05-30       Impact factor: 5.157

7.  Mammalian target of rapamycin is a direct target for protein kinase B: identification of a convergence point for opposing effects of insulin and amino-acid deficiency on protein translation.

Authors:  B T Navé; M Ouwens; D J Withers; D R Alessi; P R Shepherd
Journal:  Biochem J       Date:  1999-12-01       Impact factor: 3.857

8.  A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells.

Authors:  A Sekulić; C C Hudson; J L Homme; P Yin; D M Otterness; L M Karnitz; R T Abraham
Journal:  Cancer Res       Date:  2000-07-01       Impact factor: 12.701

9.  Regulation of cellular growth by the Drosophila target of rapamycin dTOR.

Authors:  H Zhang; J P Stallock; J C Ng; C Reinhard; T P Neufeld
Journal:  Genes Dev       Date:  2000-11-01       Impact factor: 11.361

10.  Genetic and biochemical characterization of dTOR, the Drosophila homolog of the target of rapamycin.

Authors:  S Oldham; J Montagne; T Radimerski; G Thomas; E Hafen
Journal:  Genes Dev       Date:  2000-11-01       Impact factor: 11.361

View more
  32 in total

1.  Blocking O-linked GlcNAc cycling in Drosophila insulin-producing cells perturbs glucose-insulin homeostasis.

Authors:  Osamu Sekine; Dona C Love; David S Rubenstein; John A Hanover
Journal:  J Biol Chem       Date:  2010-10-06       Impact factor: 5.157

2.  Akt determines cell fate through inhibition of the PERK-eIF2α phosphorylation pathway.

Authors:  Zineb Mounir; Jothi Latha Krishnamoorthy; Shuo Wang; Barbara Papadopoulou; Shirley Campbell; William J Muller; Maria Hatzoglou; Antonis E Koromilas
Journal:  Sci Signal       Date:  2011-09-27       Impact factor: 8.192

3.  TSC1/TSC2 and Rheb have different effects on TORC1 and TORC2 activity.

Authors:  Qian Yang; Ken Inoki; Eunjung Kim; Kun-Liang Guan
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-20       Impact factor: 11.205

4.  The drosophila T-box transcription factor midline functions within Insulin/Akt and c-Jun-N terminal kinase stress-reactive signaling pathways to regulate interommatial bristle formation and cell survival.

Authors:  Q Brent Chen; Sudeshna Das; Petra Visic; Kendrick D Buford; Yan Zong; Wisam Buti; Kelly R Odom; Hannah Lee; Sandra M Leal
Journal:  Mech Dev       Date:  2015-03-05       Impact factor: 1.882

5.  Functional analysis of the PP2A subfamily of protein phosphatases in regulating Drosophila S6 kinase.

Authors:  Vincent A Bielinski; Marc C Mumby
Journal:  Exp Cell Res       Date:  2007-05-16       Impact factor: 3.905

6.  The Drosophila protein kinase LK6 is regulated by ERK and phosphorylates the eukaryotic initiation factor eIF4E in vivo.

Authors:  Josep L Parra-Palau; Gert C Scheper; Daniel E Harper; Christopher G Proud
Journal:  Biochem J       Date:  2005-02-01       Impact factor: 3.857

7.  Cardioprotection by resveratrol: a novel mechanism via autophagy involving the mTORC2 pathway.

Authors:  Narasimman Gurusamy; Istvan Lekli; Subhendu Mukherjee; Diptarka Ray; Md Kaimul Ahsan; Mihaela Gherghiceanu; Lawrence M Popescu; Dipak K Das
Journal:  Cardiovasc Res       Date:  2009-12-03       Impact factor: 10.787

8.  Canonical and kinase activity-independent mechanisms for extracellular signal-regulated kinase 5 (ERK5) nuclear translocation require dissociation of Hsp90 from the ERK5-Cdc37 complex.

Authors:  Tatiana Erazo; Ana Moreno; Gerard Ruiz-Babot; Arantza Rodríguez-Asiain; Nicholas A Morrice; Josep Espadamala; Jose R Bayascas; Nestor Gómez; Jose M Lizcano
Journal:  Mol Cell Biol       Date:  2013-02-19       Impact factor: 4.272

9.  PDGF/VEGF signaling controls cell size in Drosophila.

Authors:  David Sims; Peter Duchek; Buzz Baum
Journal:  Genome Biol       Date:  2009-02-12       Impact factor: 13.583

10.  In vivo role of the PIF-binding docking site of PDK1 defined by knock-in mutation.

Authors:  Barry J Collins; Maria Deak; J Simon C Arthur; Laura J Armit; Dario R Alessi
Journal:  EMBO J       Date:  2003-08-15       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.